The FDA approved expanded indications of Yuflyma and its unbranded version to treat hidradenitis suppurativa in adolescents aged 12 years and older and uveitis in children aged 2 years and older, ...

US FDA approves expanded paediatric indications for Celltrion’s Yuflyma and unbranded adalimumab-aaty: Incheon, South Korea Monday, October 20, 2025, 17:00 Hrs [IST] Celltrion, ...

YUFLYMA® (adalimumab-aaty), and its unbranded version, are now approved for two additional pediatric indications - adolescent hidradenitis suppurativa (HS) and ...

Celltrion, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved expanded indications for YUFLYMA® (adalimumab-aaty) and its unbranded version, to include the treatment of ...

An overactive thyroid, aka hyperthyroidism, causes symptoms like fatigue and menstrual changes and can be dangerous to your ...

An invisible storm brews in the bodies of people developing rheumatoid arthritis They experience widespread systemic inflammation before any joint pain develops These patients also experience specific ...

Rheumatoid arthritis is a chronic autoimmune condition that cannot be cured but can be treated to prevent its progression. Individuals at risk of developing rheumatoid arthritis can be identified 3-5 ...

You could one day be spared from ever experiencing the debilitating symptoms of rheumatoid arthritis (RA)—thanks to a new discovery that could help open the door to prevention. It seems RA doesn’t ...

Scientists have discovered that rheumatoid arthritis (RA) doesn't start when the pain begins. It silently starts years earlier. RA is a debilitating autoimmune disease that causes painful joint ...

For more than four years, Lynn Milam's life was bound by the pain that radiated from her swollen joints. "My children could not hug me," she says. "I couldn't hold my husband's hand." Milam also ...

No significant differences were seen in diastolic blood pressure, augmentation index, DAS28-CRP. HealthDay News — For patients with rheumatoid arthritis (RA), methotrexate significantly reduces ...

People with rheumatoid arthritis usually depend on drugs to control pain in their joints. But this summer, the Food and Drug Administration approved a different sort of treatment. It's a device that ...